Reprint
Nanobody
Edited by
March 2021
300 pages
- ISBN978-3-0365-0378-3 (Hardback)
- ISBN978-3-0365-0379-0 (PDF)
This book is a reprint of the Special Issue Nanobody that was published in
Biology & Life Sciences
Summary
Nanobodies have become outstanding tools for biomedical research, diagnostics and therapy. Recent advances in the identification and functionalization of target-specific nanobodies now make nanobody-based approaches broadly available to many researches in the field. This book provides a compilation of original research articles and comprehensive reviews covering important and up to date aspects of research on nanobodies and their applications for immunoassays, proteomics, protein crystallization and in vitro and in vivo imaging.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
Bacillus anthracis; immunoassay; single-domain antibody; genetic fusion; Beta galactosidase; P-type ATPase; nanobody; llama; Zinc-transport; Zinc-transporting P-ATPase; ZntA; TNF; fluorescent; nanobodies; sensor; anti-cytokine therapy; autoimmune disease; single-domain antibody; Western equine encephalitis virus; MagPlex; toxin; antibody; camelid; vaccine; biodefense; hydrogen exchange-mass spectrometry; virus; nanobody; formatting; Fc-domain; half-life; nanobodies; ischemia; stroke; MCAO; single domain antibodies; nanobody; phage display; intrabody; intracellular antibody; GTPase RHO; BRET; RAS; nanobodies; chromobodies; live-cell imaging; compound screening; cellular models; single-domain antibody fragments; molecular imaging; molecular therapy; nuclear imaging; targeted fluorescence imaging; intraoperative imaging; Nanobody; Single Domain Antibody; Cancer; Immunotherapy; Imaging; influenza; influenza B virus; hemagglutinin; single domain antibody; NanobodyTM; phage display; yeast display; epitope mapping; nanobody; GFP; C. elegans; development; drosophila; zebrafish; targeted photodynamic therapy; hepatocyte growth factor receptor; HGFR; c-Met; Met; nanobodies; VHH; photosensitizer; single-domain antibodies; neurodegenerative diseases; brain imaging; blood–brain barrier; delivery; Aids; HIV; Llama Antibodies; bi-specific VHH; pepscan; competition studies; epitope mapping; co-crystallisation; n/a